Claritev Insider Executes Stock Sale Valued at $1.8 Million
An insider at Claritev Corporation has sold company shares totaling approximately $1.82 million, according to a recent regulatory filing.
Stocks · News reference
Claritev Corporation has announced its participation in the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
An insider at Claritev Corporation has sold company shares totaling approximately $1.82 million, according to a recent regulatory filing.
Wells Fargo analyst Stan Berenshteyn has maintained a 'Hold' rating on Claritev (CTEV) and raised the price target from $22 to $30.
CCORF analyst Richard Close maintained a Buy rating on Claritev and increased the price target from $43 to $47.
Claritev (NYSE:CTEV) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Claritev Corporation announced its financial results for the third quarter ended September 30, 2026, reporting revenue growth and updated full-year guidance.